Clinical Trial Update: Endothelial Cell Dysfunction in Pulmonary Hypertension [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating endothelial cell dysfunction in pulmonary hypertension has completed. The study focused on secondary pulmonary arterial hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Secondary Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED